期刊文献+

肺癌患者手术前后血清Lipocalin-2、MMP-9表达的临床意义 被引量:2

Expression and clinical significance of serum Lipocalin-2 and MMP-9 before and after operation in patients with lung cancer
下载PDF
导出
摘要 目的研究肺癌患者手术前后血清脂质运载蛋白-2(Lipocalin-2)、基质金属蛋白酶-9(MMP-9)的表达及临床意义。方法采用酶联免疫吸附法(ELISA)检测60例肺癌患者手术前后Lipocalin-2、MMP-9蛋白水平,分析其与临床病理特征的关系。结果肺癌组Lipocalin-2、MMP-9表达水平显著高于健康对照组(P<0.05)。二者表达与TNM临床分期、淋巴结转移状况有关(P<0.05),且呈正相关(r=7.217,P<0.05)。手术治疗总有效率为80.0%,治疗后Lipocalin-2、MMP-9水平显著降低,与治疗前比较差异有统计学意义(P<0.05)。结论肺癌组Lipocalin-2、MMP-9异常高表达,这与肺癌侵袭转移过程密切相关。手术治疗可显著降低二者表达水平,对其表达水平的监测可作为判断手术疗效和评估预后的可靠指标。 Obje ctive To investigate the expression and clinical significance of Lipocalin -2 and MMP-9 before and after operation in patients with lung cancer .Methods The serum levels of Lipocalin-2 and MMP-9 before and after operation were detected by ELISA in 60 patients with lung cancer and 50 healthy subjects.The correlation between the expressions and clinical pathological characteristics was analyzed .Results The serum levels of Lipocalin-2 and MMP-9 in patients with lung cancer were significantly higher than those of healthy subjects ( P &lt;0.05).The expression levels of Lipocalin -2 and MMP-9 were closely correlated to clinical staging and lymph node metastasis ( P &lt;0.05),and the expression levels of Lipocalin-2 were positively related to those of MMP-9 ( r =7.217, P &lt;0.05).The total effective rate of operation was 80.0%.The serum levels of Lipocalin-2 and MMP-9 were significantly decreased after operation ,as compared with those before operation ( P &lt;0.05).There were significant differences in the serum levels of Lipocalin -2,MMP-9 betweem the patients with relapse and the patients without relapse ( P &lt;0.05).C onclusion The overexpression of Lipocalin-2 and MMP-9 is closely related with invasion and metastasis process of lung cancer ,which may play an important role in carcinogenesis ,invasion and metastasis of lung cancer.After operation,the Lipocalin-2 and MMP-9 levels are significantly decreased,and the detection of serum levels of Lipocalin-2 and MMP-9 may be regarded as reliable indexes for evaluating operation efficiency and patient &#39;s prognosis.
出处 《河北医药》 CAS 2014年第9期1288-1290,共3页 Hebei Medical Journal
关键词 肺肿瘤 Lipocalin-2 MMP-9 手术 lung cancer lipocalin-2 MMP-9 operation
  • 相关文献

参考文献5

二级参考文献23

  • 1Flower DR. The lipocalin protein family:structure and function[J]. Biochem J, 1996, 318(Pt 1): 1-14. 被引量:1
  • 2Tong ZM, Wu XL, Ovcharenko D, et al. Neutrophil genatinase- associated lipocalin as a survival factor[J]. Biochem J, 2005, 391(Pt2): 441-448. 被引量:1
  • 3Grundy SM. The metabolic syndrome:inflammation,diabetes mellitus,and cardiovascular disease[J]. Am J Cardio, 2006, 97(1): 3A-11A. 被引量:1
  • 4Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly[J]. Circ Res, 2002, 90(3): 251-262. 被引量:1
  • 5Stoesz SP, Friedl A, Haag JD, et al. Heterogeneous expression of the lipocalin NGAL in primary breast cancers[J]. Int J Cancer, 1998, 79(6): 565-572. 被引量:1
  • 6BauerM, Eickhoff JC, GouldMN, et al. Neutrophil gelatinase- associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer[J]. Breast Cancer Res Treat, 2008, 108(3): 389-397. 被引量:1
  • 7Syrjanen S, Naud P, Sarian L, et al. Up-regulation of lipocalin 2 is associated with high-risk human papillomavirus and grade of cervical lesion at baseline but does not predict outcomes of infections or incident cervical intraepithelial neoplasia[J]. Am J Clin Pathol, 2010, 134(1): 50-59. 被引量:1
  • 8Mannelqvist M, Stefansson I, Wik E, et al. Lipocalin 2 expression is associated with aggressive features of endometrial Cancer[J]. BMC Cancer, 2012, 12(5): 169. 被引量:1
  • 9Waters JS,O'Brien MER.The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence(NICE).Br J Cancer,2002,87:481-490. 被引量:1
  • 10Cox G,Jones JL,O'Byrne KJ.Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.Clin Cancer Res,2000,6:2349-2355. 被引量:1

共引文献16

同被引文献24

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部